Previous symbols: UVO. Aliases: uvomorulin, CD324.
CDH1 encodes E-cadherin (epithelial cadherin), the prototypical type-I classical cadherin and the principal calcium-dependent cell-cell adhesion molecule of epithelia. This single-pass transmembrane glycoprotein has five extracellular cadherin (EC) repeats that bind calcium and mediate homophilic trans-adhesion with E-cadherin on neighbouring cells, while its cytoplasmic tail nucleates the cadherin-catenin complex by binding p120-catenin, beta-catenin and gamma-catenin/plakoglobin; alpha-catenin in turn couples this complex to the cortical actin cytoskeleton. Through these interactions E-cadherin builds and maintains adherens junctions, establishes epithelial apicobasal polarity and tissue integrity, and facilitates early desmosome assembly. E-cadherin is a potent invasion and tumour suppressor: loss of function promotes epithelial-to-mesenchymal transition and is causative in hereditary diffuse gastric cancer and lobular breast carcinoma. E-cadherin is additionally exploited as a host cell-surface receptor by Listeria monocytogenes internalin A.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| CDH1-Related Hereditary Diffuse Gastric Cancer | causative germline loss of function |
mechanism: Germline CDH1 First-Hit Inactivation
|
| Gastric Adenocarcinoma | causative germline |
mechanism: CDH1 Inactivation and E-cadherin Loss
subtype: Diffuse; HDGC
scoped to subtype: HDGC
|
| Gastric Cancer H. pylori Associated |
untyped
Somatic and Germline Mutations
|
mechanism: CDH1/E-cadherin Inactivation
|
| Ulcerative Colitis |
untyped
Risk Factor
|
mechanism: Epithelial Barrier Dysfunction
|
| Arthrogryposis-Renal Dysfunction-Cholestasis Syndrome | no genetic record |
mechanism: Loss of Apical-Basolateral Epithelial Polarity
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| CDH1-related diffuse gastric and lobular breast cancer syndrome MONDO:0100488 | AD | Definitive 2024-03-22 |
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.